FDA Clearance Tracker · P930038-S022
ANGIO-SEAL HEMOSTATIC PUNCTURE CLOSURE DEVICE
Last checked: Nov 20, 2026Latest source record: Apr 6, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Apr 6, 2000
Approved
Time to decision
112 days
Received Dec 16, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P930038-S022
- Device name
- ANGIO-SEAL HEMOSTATIC PUNCTURE CLOSURE DEVICE
- Applicant
- Terumo Medical Corporation
- Applicant location
- Elkton, MD
- Received
- Dec 16, 1999
- Decided
- Apr 6, 2000
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P930038
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a modification to the 8F Angio-Seal device to include a monofold design for the insertion sheath component.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.